NOT-CA-22-124: Pre-Application Webinar for RFA-CA-22-019, Global Implementation Science for Equitable Cancer Control (GlobalISE Cancer Control, U54 Clinical Trial Optional)

Pre-Application Webinar for RFA-CA-22-019, Global Implementation Science for Equitable Cancer Control (GlobalISE Cancer Control, U54 Clinical Trial Optional)

Notice Number:

NOT-CA-22-124

Key Dates

Release Date:

August 30, 2022

Related Announcements

RFA-CA-22-019 - Global Implementation Science for Equitable Cancer Control (GlobalISE Cancer Control, U54 Clinical Trial Optional)

Issued by

National Cancer Institute (NCI)

Purpose

The National Cancer Institute (NCI) will hold a pre-application webinar on Tuesday, September 20, 2022, from 11:00 AM - 12:00 PM (ET) for the Funding Opportunity Announcement (FOA) RFA-CA-22-019 entitled " Global Implementation Science for Equitable Cancer Control (GlobalISE Cancer Control, U54 Clinical Trial Optional).”

NCI staff members involved in the FOA will provide a brief overview of the above-referenced FOA for potential applicants by explaining the goals and objectives of the FOA, as well as answering questions from webinar attendees.

Please submit questions by September 16, 2022 to [email protected]. Attendees will also be able to submit questions during the webinar. Questions submitted early will be answered first.

Webinar Information

Join ZoomGov Meeting:
https://nih.zoomgov.com/j/1614399920?pwd=SExybThzK05NSWhodzZGZStURnc4dz09

Meeting ID: 161 439 9920
Passcode: 332856
One tap mobile
+16692545252,,1614399920#,,,,*332856# US (San Jose)
+16468287666,,1614399920#,,,,*332856# US (New York)

Dial by your location
+1 669 254 5252 US (San Jose)
+1 646 828 7666 US (New York)
+1 551 285 1373 US
+1 669 216 1590 US (San Jose)
Meeting ID: 161 439 9920
Passcode: 332856
Find your local number: https://nih.zoomgov.com/u/ab8mspBsL6

Join by SIP
sip:[email protected]

Join by H.323
161.199.138.10 (US West)
161.199.136.10 (US East)

Participation in this webinar, although encouraged, is optional and is not required for the submission of an application in response to RFA-CA-22-019. A document highlighting frequently asked questions and corresponding answers will be posted to the Center for Global Health website following the webinar.

Inquiries

Please direct all inquiries to:

Gila Neta, Ph.D.
National Cancer Institute (NCI)
Telephone: 240-276-6785
Email: [email protected]

Vidya Vedham, Ph.D.
National Cancer institute (NCI)
Telephone: 240-276-7272
Email: [email protected]